Deterministic targeting and activation of brand-eligible consumers – so you shouldn't have to limit states due to privacy regulations, rely on cookies, or turn to lookalike audiences.
Deterministic targeting and activation of brand-eligible consumers – so you shouldn't have to limit states due to privacy regulations, rely on cookies, or turn to lookalike audiences.
In today's world of increasingly scrutinized consumer targeting practices, our patented Micro-Neighborhood® Targeting (MNT) platform is trusted by over 150 pharmaceutical brands to reach brand eligible patients while addressing Washington state’s My Health My Data Act (MHMDA) and other emerging state regulations.
MNT provides a deterministic alternative to commonly used (and often riskier) targeting approaches, such as lookalikes or cookies, while allowing life science brands to identify, prioritize, and reach their patients in hyper-granular, local clusters.
Reach and engage your ideal patient audiences, regardless of where they live or their preferred media -- including often underserved areas.
We utilize real-world medical evidence including a vast warehouse of open and closed medical claims, commercial and specialty prescription claims, as well an array of consumer attributes and social determinants of health to identify high indexing hyperlocal geographic areas for targeted advertising.
While many vendors in the industry rely on look-alike, contextualized, and modeled audiences to serve ads to potentially brand-eligible patients, OptimizeRx works with safe harbor partners and employs our patented deterministic methods.
When developing campaigns you want to consider all attributes of your audience. For example, a type 2 diabetic living in Baton Rouge, LA may have a very different lifestyle than one who lives in Spokane, WA. MNT enables you to consider those differences in your creative and messaging making it more personalized and relevant.
Patented tokenization technology associates de-identified prescription and medical claims data to consumer-level data, allowing for full compliance with HIPAA, as well as Washington state’s MHMDA and other state regulations, including Colorado, Connecticut, Nevada, Oregon, Utah, and Virginia.
Award winning, multi-party data linking technology combines the fidelity of first-party data with the privacy of hashed, third-party identifiers – maintaining data privacy while maximizing targeting precision.
Scores and ranks 35M+ hyperlocal, zip-9 areas based on the real-world prevalence of your patient audience(s), then selectively deploys omnichannel media to just the zip-9 areas with proven brand-eligible patients
Choose from stand-alone custom audience development, or let our experts be an extension of your internal or agency team.
We’re here to help you capitalize on the latest marketing science. Our patient-centric, patented solutions dynamically segment, prioritize, and engage HCP and consumer audiences, delivering superior performance and script lift.
Bring your brand strategies to life – and deliver incredible results for your clients. We make it easier for our agency partners to incorporate more precise audience targeting and omnichannel delivery into their marketing campaigns.
Drive brand growth with unprecedented predictive audience intelligence and smarter program execution
Let’s talk about your brand marketing needs and how our dynamic, patient-centric solutions help achieve your commercial goals.